Eckhouse Seth, Lewison Grant, Sullivan Richard
European Cancer Research Managers Forum, London, UK.
Mol Oncol. 2008 Jun;2(1):20-32. doi: 10.1016/j.molonc.2008.03.007. Epub 2008 Mar 27.
Cancer research has carved an astonishing trajectory giving rise to a multi billion euro global network covering most domains of science and including all manner of research funders from industry to government and philanthropic funders. We have estimated that in 2004/2005 the global spend on cancer research was 14,030 million euro, with the USA, dominated by the NCI (c. 83%) accounting for the largest absolute spend. This is between 2 and 3 times the level of per capita spend compared to EU-15 and Europe, respectively. In Europe, the UK is at comparable levels of spend compared to the USA. Funding for cancer research in Europe is split almost 50:50 between philanthropic and governmental sources. Cancer research productivity in terms of outputs (publications) is slightly greater in Europe compared to the USA with an increasing trend towards more applied (clinical) outputs. Both the USA and Europe have equally strong industry-supported output levels.
癌症研究已经走过了一条令人惊叹的轨迹,形成了一个价值数十亿欧元的全球网络,涵盖了科学的大多数领域,包括从行业到政府以及慈善资助者等各种各样的研究资助者。我们估计,在2004/2005年,全球癌症研究支出为140.3亿欧元,其中美国以美国国立癌症研究所(约占83%)为主导,支出绝对值最大。与欧盟15国和欧洲相比,这分别是人均支出水平的2至3倍。在欧洲,英国的支出水平与美国相当。欧洲癌症研究的资金来源中,慈善和政府来源几乎各占一半。就产出(出版物)而言,欧洲的癌症研究生产力略高于美国,且越来越倾向于更具应用性(临床)的产出。美国和欧洲的行业支持产出水平同样强劲。